drugset / Trial / NCT06722417
A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese Participants
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This study will assess the pharmacokinetics, safety, and tolerability of icalcaprant administered orally in healthy adult Japanese and Han Chinese participants.
Timeline
- Start
- 2024-11-26
- Primary completion
- 2025-01-17
- Completion
- 2025-01-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icalcaprant | Small molecule | — | Oral |
Indications
No indication recorded.